Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Armed with EU stroke approval, Pfizer, BMS talk up Eliquis' edge over rivals
Fierce Pharma
Wednesday, November 21, 2012 - 12:28pm
tags:
Europe, stroke, Pfizer, Eliquis, bloodthinners, Bristol-Myers Squibb
Can InterMune Sustain Positive Momentum?
Seeking Alpha
Wednesday, November 21, 2012 - 12:17pm
tags:
InterMune
This Healthcare Giant Needs to Focus on Organic Growth
Motley Fool
Wednesday, November 21, 2012 - 11:21am
tags:
JNJ
Is There An Opportunity With Tranzyme After Stock Falls Over 75%?
Seeking Alpha
Wednesday, November 21, 2012 - 11:20am
tags:
Tranzyme
Revisiting Buyout Rumors After Teva's CEO Shifts Focus To 'Smaller Acquisitions'
Seeking Alpha
Wednesday, November 21, 2012 - 11:15am
tags:
Teva, M&A, Bristol-Myers Squibb, Eli Lilly, Novartis, Prolor, Pfizer
Impax signs development agreement with Perrigo
Yahoo/Fly on the Wall
Wednesday, November 21, 2012 - 11:11am
tags:
Perrigo, Impax Labs
Savient Pharma: Still Struggling To Grow KRYSTEXXA Sales
Seeking Alpha
Wednesday, November 21, 2012 - 10:44am
tags:
Savient, Krystexxa, gout
FDA approves Novartis cell culture flu vaccine
Pharma Times, UK
Wednesday, November 21, 2012 - 10:42am
tags:
FDA, Novartis, Flu, vaccines, Flucelvax
The Medicines Co. trades higher after analyst highlights company's pipeline
Yahoo/AP
Wednesday, November 21, 2012 - 10:41am
tags:
Medicines Company
Why Dynavax's HEPLISAV Is Likely To Be Approved: Impact On Future Vaccine Development
Seeking Alpha
Wednesday, November 21, 2012 - 10:40am
tags:
Dynavax, Heplisav, vaccines, FDA
Pfizer: Does it Need a Future Substitute for Lyrica?
Motley Fool
Wednesday, November 21, 2012 - 10:39am
tags:
Pfizer, Lyrica
3 Things to Watch With Antares Pharma
Motley Fool
Wednesday, November 21, 2012 - 10:39am
tags:
Antares Pharma, Vibex MTX, Teva, Ferring
TauRx nabs $112M to back Phase III Alzheimer's program
Fierce Biotech
Tuesday, November 20, 2012 - 1:32pm
tags:
TauRx, Alzheimer's disease
Overnight success proves elusive for oral MS drugs
Fierce Pharma
Tuesday, November 20, 2012 - 1:25pm
tags:
multiple sclerosis, MS, Novartis, Gilenya, Sanofi, Aubagio
A Fact Based Analysis Of Galena's NeuVax
Seeking Alpha
Tuesday, November 20, 2012 - 1:18pm
tags:
Galena Biopharma, NeuVax
Several Biopharmas That Look Ready For Upside Gains
Yahoo/Reuters
Tuesday, November 20, 2012 - 1:18pm
tags:
Sarepta, BG Medicine, Amicus, Santarus, Celldex
PDL BioPharma, AxoGen Benefit From 'Royal' Agreement
Seeking Alpha
Tuesday, November 20, 2012 - 1:16pm
tags:
PDL Biopharma, AxoGen
SEC alleges largest-ever insider-trading scheme
Marketwatch
Tuesday, November 20, 2012 - 1:13pm
tags:
SEC, insider trading, Elan, Pfizer, Wyeth
Nestle Purchase of Pfizer Unit Blocked in Mexico
Bloomberg
Tuesday, November 20, 2012 - 1:12pm
tags:
Nestle, Pfizer, Mexico, M&A, infant nutrition
Aeterna Zentaris: Late-Stage Drug Candidates Could Send Stock Higher
Seeking Alpha
Tuesday, November 20, 2012 - 11:36am
tags:
Aeterna Zentaris, AEZS-108, perifosine, AEZS-130

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.